Research Article: Co-Delivery Nanomicelles for Potentiating TNBC Immunotherapy by Synergetically Reshaping CAFs-Mediated Tumor Stroma and Reprogramming Immunosuppressive Microenvironment
Introduction:
Triple negative breast cancer (TNBC), the most aggressive subtype of breast cancer, is characterized by high intratumoral heterogeneity, a lack of established molecular targets, low overall survival rates, and high recurrence rates. While some metastatic TNBC patients have experienced clinical benefits from programmed cell death- (PD-) or programmed cell death-ligand (PD-L) inhibitors through the innovation of T cell-mediated immunotherapies, the overall response rate to immune checkpoint inhibitors (ICI) remains…
Read more